Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 117 Pages
Report ld: 5535437
Request Sample
Customized Report
Disposable Hemoperfusion Market Size(US$)

CAGR 2026-2032
13.0%
Market Size,2032
USD 3,430
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Disposable Hemoperfusion market was valued at US$ 1475 million in 2025 and is anticipated to reach US$ 3430 million by 2032, at a CAGR of 13.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Disposable Hemoperfusion competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient"s body. In this report, we calculate medical consumables of hemoperfusion.
China is the largest market with about 48% market share. Followed by Europe and Japan, accounting for about 35% market share.
The key players are Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical etc. Top 3 companies occupied about 64% revenue market share.
This report delivers a comprehensive overview of the global Disposable Hemoperfusion market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Disposable Hemoperfusion. The Disposable Hemoperfusion market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Disposable Hemoperfusion market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Disposable Hemoperfusion manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Disposable Hemoperfusion manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Disposable Hemoperfusion sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Disposable Hemoperfusion Market Overview
1.1 Product Definition
1.2 Disposable Hemoperfusion by Type
1.2.1 Global Disposable Hemoperfusion Market Value by Type: 2025 vs 2032
1.2.2 Charcoal Hemoperfusion
1.2.3 Certain Resins Hemoperfusion
1.3 Disposable Hemoperfusion by Application
1.3.1 Global Disposable Hemoperfusion Market Value by Application: 2025 vs 2032
1.3.2 Overdose
1.3.3 Specific Intoxications
1.3.4 Certain Autoimmune Diseases
1.3.5 Hepatic Encephalopathy
1.3.6 Others
1.4 Global Disposable Hemoperfusion Market Size Estimates and Forecasts
1.4.1 Global Disposable Hemoperfusion Revenue 2021–2032
1.4.2 Global Disposable Hemoperfusion Sales 2021–2032
1.4.3 Global Disposable Hemoperfusion Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Disposable Hemoperfusion Market Competition by Manufacturers
2.1 Global Disposable Hemoperfusion Sales Market Share by Manufacturers (2021–2026)
2.2 Global Disposable Hemoperfusion Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Disposable Hemoperfusion Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Disposable Hemoperfusion, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Disposable Hemoperfusion, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Disposable Hemoperfusion, Product Types and Applications
2.7 Global Key Manufacturers of Disposable Hemoperfusion, Date of Entry into the Industry
2.8 Global Disposable Hemoperfusion Market Competitive Situation and Trends
2.8.1 Global Disposable Hemoperfusion Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Disposable Hemoperfusion Players Market Share by Revenue
2.8.3 Global Disposable Hemoperfusion Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Disposable Hemoperfusion Market Scenario by Region
3.1 Global Disposable Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Disposable Hemoperfusion Sales by Region: 2021–2032
3.2.1 Global Disposable Hemoperfusion Sales by Region: 2021–2026
3.2.2 Global Disposable Hemoperfusion Sales by Region: 2027–2032
3.3 Global Disposable Hemoperfusion Revenue by Region: 2021–2032
3.3.1 Global Disposable Hemoperfusion Revenue by Region: 2021–2026
3.3.2 Global Disposable Hemoperfusion Revenue by Region: 2027–2032
3.4 North America Disposable Hemoperfusion Market Facts & Figures by Country
3.4.1 North America Disposable Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Disposable Hemoperfusion Sales by Country (2021–2032)
3.4.3 North America Disposable Hemoperfusion Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Disposable Hemoperfusion Market Facts & Figures by Country
3.5.1 Europe Disposable Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Disposable Hemoperfusion Sales by Country (2021–2032)
3.5.3 Europe Disposable Hemoperfusion Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Disposable Hemoperfusion Market Facts & Figures by Region
3.6.1 Asia Pacific Disposable Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Disposable Hemoperfusion Sales by Region (2021–2032)
3.6.3 Asia Pacific Disposable Hemoperfusion Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Disposable Hemoperfusion Market Facts & Figures by Country
3.7.1 Latin America Disposable Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Disposable Hemoperfusion Sales by Country (2021–2032)
3.7.3 Latin America Disposable Hemoperfusion Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Disposable Hemoperfusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Disposable Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Disposable Hemoperfusion Sales by Country (2021–2032)
3.8.3 Middle East and Africa Disposable Hemoperfusion Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Disposable Hemoperfusion Sales by Type (2021–2032)
4.1.1 Global Disposable Hemoperfusion Sales by Type (2021–2026)
4.1.2 Global Disposable Hemoperfusion Sales by Type (2027–2032)
4.1.3 Global Disposable Hemoperfusion Sales Market Share by Type (2021–2032)
4.2 Global Disposable Hemoperfusion Revenue by Type (2021–2032)
4.2.1 Global Disposable Hemoperfusion Revenue by Type (2021–2026)
4.2.2 Global Disposable Hemoperfusion Revenue by Type (2027–2032)
4.2.3 Global Disposable Hemoperfusion Revenue Market Share by Type (2021–2032)
4.3 Global Disposable Hemoperfusion Price by Type (2021–2032)
5 Segment by Application
5.1 Global Disposable Hemoperfusion Sales by Application (2021–2032)
5.1.1 Global Disposable Hemoperfusion Sales by Application (2021–2026)
5.1.2 Global Disposable Hemoperfusion Sales by Application (2027–2032)
5.1.3 Global Disposable Hemoperfusion Sales Market Share by Application (2021–2032)
5.2 Global Disposable Hemoperfusion Revenue by Application (2021–2032)
5.2.1 Global Disposable Hemoperfusion Revenue by Application (2021–2026)
5.2.2 Global Disposable Hemoperfusion Revenue by Application (2027–2032)
5.2.3 Global Disposable Hemoperfusion Revenue Market Share by Application (2021–2032)
5.3 Global Disposable Hemoperfusion Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter International
6.1.1 Baxter International Company Information
6.1.2 Baxter International Description and Business Overview
6.1.3 Baxter International Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter International Disposable Hemoperfusion Product Portfolio
6.1.5 Baxter International Recent Developments/Updates
6.2 Asahi Kasei Corporation
6.2.1 Asahi Kasei Corporation Company Information
6.2.2 Asahi Kasei Corporation Description and Business Overview
6.2.3 Asahi Kasei Corporation Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Asahi Kasei Corporation Disposable Hemoperfusion Product Portfolio
6.2.5 Asahi Kasei Corporation Recent Developments/Updates
6.3 CytoSorbentsCompany 11
6.3.1 CytoSorbentsCompany 11 Company Information
6.3.2 CytoSorbentsCompany 11 Description and Business Overview
6.3.3 CytoSorbentsCompany 11 Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CytoSorbentsCompany 11 Disposable Hemoperfusion Product Portfolio
6.3.5 CytoSorbentsCompany 11 Recent Developments/Updates
6.4 Kaneka Pharma
6.4.1 Kaneka Pharma Company Information
6.4.2 Kaneka Pharma Description and Business Overview
6.4.3 Kaneka Pharma Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Kaneka Pharma Disposable Hemoperfusion Product Portfolio
6.4.5 Kaneka Pharma Recent Developments/Updates
6.5 Toray Medical
6.5.1 Toray Medical Company Information
6.5.2 Toray Medical Description and Business Overview
6.5.3 Toray Medical Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Toray Medical Disposable Hemoperfusion Product Portfolio
6.5.5 Toray Medical Recent Developments/Updates
6.6 Aier
6.6.1 Aier Company Information
6.6.2 Aier Description and Business Overview
6.6.3 Aier Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aier Disposable Hemoperfusion Product Portfolio
6.6.5 Aier Recent Developments/Updates
6.7 Tianjin Zibo High Technology
6.7.1 Tianjin Zibo High Technology Company Information
6.7.2 Tianjin Zibo High Technology Description and Business Overview
6.7.3 Tianjin Zibo High Technology Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Tianjin Zibo High Technology Disposable Hemoperfusion Product Portfolio
6.7.5 Tianjin Zibo High Technology Recent Developments/Updates
6.8 Biosun Corporation
6.8.1 Biosun Corporation Company Information
6.8.2 Biosun Corporation Description and Business Overview
6.8.3 Biosun Corporation Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biosun Corporation Disposable Hemoperfusion Product Portfolio
6.8.5 Biosun Corporation Recent Developments/Updates
6.9 Kangbei Medical Device
6.9.1 Kangbei Medical Device Company Information
6.9.2 Kangbei Medical Device Description and Business Overview
6.9.3 Kangbei Medical Device Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kangbei Medical Device Disposable Hemoperfusion Product Portfolio
6.9.5 Kangbei Medical Device Recent Developments/Updates
6.10 Jafron Biomedical
6.10.1 Jafron Biomedical Company Information
6.10.2 Jafron Biomedical Description and Business Overview
6.10.3 Jafron Biomedical Disposable Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jafron Biomedical Disposable Hemoperfusion Product Portfolio
6.10.5 Jafron Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Disposable Hemoperfusion Industry Chain Analysis
7.2 Disposable Hemoperfusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Disposable Hemoperfusion Production Mode & Process Analysis
7.4 Disposable Hemoperfusion Sales and Marketing
7.4.1 Disposable Hemoperfusion Sales Channels
7.4.2 Disposable Hemoperfusion Distributors
7.5 Disposable Hemoperfusion Customer Analysis
8 Disposable Hemoperfusion Market Dynamics
8.1 Disposable Hemoperfusion Industry Trends
8.2 Disposable Hemoperfusion Market Drivers
8.3 Disposable Hemoperfusion Market Challenges
8.4 Disposable Hemoperfusion Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Disposable Hemoperfusion market size was US$ 1475 million in 2025 and is forecast to reach a readjusted size of US$ 3430 million by 2032 with a CAGR of 13.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1475 million in 2025 and is projected to reach US$ 3430 million, growing at a CAGR of 13.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 93
USD 3950.00
(Single User License)
The global Disposable Hemoperfusion market is projected to grow from US$ 1320 million in 2024 to US$ 3070 million by 2031, at a CAGR of 13.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 144
USD 4900.00
(Single User License)
In 2024, the global market size of Disposable Hemoperfusion was estimated to be worth US$ 1320 million and is forecast to reach approximately US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 128
USD 5900.00
(Single User License)
The global Disposable Hemoperfusion market size was US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 108
USD 3950.00
(Single User License)
The global market for Disposable Hemoperfusion was valued at US$ 1320 million in the year 2024 and is projected to reach a revised size of US$ 3070 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published Date: 2024-04-17
Pages: 157
USD 5600.00
(Single User License)
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published Date: 2024-04-16
Pages: 152
USD 5900.00
(Single User License)
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published Date: 2024-04-07
Pages: 105
USD 4900.00
(Single User License)
The global Disposable Hemoperfusion market size was US$ 1475 million in 2025 and is forecast to reach a readjusted size of US$ 3430 million by 2032 with a CAGR of 13.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1475 million in 2025 and is projected to reach US$ 3430 million, growing at a CAGR of 13.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 93
The global Disposable Hemoperfusion market is projected to grow from US$ 1320 million in 2024 to US$ 3070 million by 2031, at a CAGR of 13.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 144
In 2024, the global market size of Disposable Hemoperfusion was estimated to be worth US$ 1320 million and is forecast to reach approximately US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 128
The global Disposable Hemoperfusion market size was US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
The global market for Disposable Hemoperfusion was estimated to be worth US$ 1320 million in 2024 and is forecast to a readjusted size of US$ 3070 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 108
The global market for Disposable Hemoperfusion was valued at US$ 1320 million in the year 2024 and is projected to reach a revised size of US$ 3070 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Published: 2025-01-16
Pages: 79
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published: 2024-04-17
Pages: 157
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published: 2024-04-16
Pages: 152
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
Published: 2024-04-07
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now